We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TEVA OPPOSES PUSH FOR ISRAEL TO ADOPT 10-YEAR DATA EXCLUSIVITY
TEVA OPPOSES PUSH FOR ISRAEL TO ADOPT 10-YEAR DATA EXCLUSIVITY
April 30, 2004
Israel-based generic firm Teva Pharmaceutical is objecting to what it contends is pressure from U.S. trade officials that Israel adopt a 10-year data exclusivity period for drugs — a period twice as long as that in the U.S.